Sesame Oil

Phase 1Small molecule

PPennington Biomedical Research Center

Sesame Oil is one of 28 small molecule programs targeting Oral Lichen Planus. It is currently in Phase 1.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Oral Lichen PlanusActive, not recruiting

Oral Lichen PlanusPhase 1

Active, not recruiting

Competition

Competitive Landscape

81 competitors in Oral Lichen Planus

#DrugCompanyPhaseTrials

Azulfidine

Pfizer

Phase 3

1 2

Decadron

AAspen Global Incorporated

Phase 3

3 3

Elidel

BBausch Health Americas, Inc.

Phase 3

2 4

PROCRIT

WWim Janssens

Phase 3

1 5

Minocin

TTriax

Phase 3

1 6

Advil

KKenvue Brands

Phase 3

1 7

Curcumin

Merck & Co.

Phase 3

1 8

Plaquenil

Alnylam Pharmaceuticals

Phase 2

1 9

Olumiant

Eli Lilly

Phase 2

1 10

Olux

HHarrow Inc

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Testosterone2 trials

Trial of Testosterone Undecanoate for Optimizing Performance During Military Operations

Completed·PPennington Biomedical Research Center·Phase 4·NCT04120363·34 enrolled

Physiological and Psychological Effects of Testosterone During Severe Energy Deficit and Recovery

Completed·PPennington Biomedical Research Center·Phase 4·NCT02734238·53 enrolled

Oral Lichen Planus1 trial

The Efficacy of Topical Sesame Oil Versus Topical Triamcinolone on Oral Lichen Planus and Salivary Level of Oxidative Stress Biomarker [MDA]

Unknown status·MMona Taha Mohammed MD·Phase 1·NCT03738176·40 enrolled

MPA1 trial

Comparing of Sesame Oil, Nitroglycerin Ointment, and Aloe Vera Gel

Not yet recruiting·UUniversity of Basrah·Phase 2·NCT07346677·190 enrolled

Sources

References

[1]
ClinicalTrials.gov — 4 trial records for Sesame Oil. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Sesame Oil compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Sesame Oil. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Pennington Biomedical Research Center company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 1[1]
Company: PPennington Biomedical Research Center

Sesame Oil

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Testosterone2 trials

Oral Lichen Planus1 trial

MPA1 trial

References

Drug Info

Quick Facts

Related News